Skip to content

AAGEM MEDICS

Active
Private limited companyfounded 2009active for 17 yearsSint-Onolfsdijk (DEN) 16, 9200 Dendermonde, BelgiumKBO/BCE: BE 0811.003.043
Summary

AAGEM MEDICS has been active since 2009 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €240,854 and a net result of €25,638. Equity is growing by about 19% per year across the filed financial years. The computed 12-month bankruptcy probability is 0.2% (very low).

Overview

Activity
“Het verwerven door aankoop en/of bouw van alle onroerende goederen” (deed in Dutch)
From the articles, 6 activitiesNo NACE code in the KBO yet
Size
≈ €160,000turnover 2025, estimated
Equity
€240,854
Profit
€25,638
Turnover estimated from the gross margin
Financial health
91 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Structure
Largest shareholder
DOKTER PIETER VAN ACKER · 49%
2025 accounts 63 days early
Why 91raises riskNo registered site in the KBOlowers riskSize: total assets €266,668Founded in 2009Equity €240,854 (90.3% of total assets)Show the evidence

Checked score

Score 2025
91 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 67% of its sector peers (no NACE code, micro)
Financial strength · tick = 2024
Strong
Solvency 100+2
equity 90.3% of total assets
Liquidity 56+4
short-term debt 9.0% · cash 4.6%
Profitability 81-1
return on assets 9.6%
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 11-2024: 0.2% 12-2024: 0.2%● unchanged vs 11-2024 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.2%● unchanged vs 05-2025highest value 07-2025: 0.1%▼ -0.1 percentage points vs 06-2025lowest value 08-2025: 0.1%● unchanged vs 07-2025lowest value 09-2025: 0.1%● unchanged vs 08-2025lowest value 10-2025: 0.1%● unchanged vs 09-2025lowest value 11-2025: 0.1%● unchanged vs 10-2025lowest value 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.2%▲ +0.1 percentage points vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.2%● unchanged vs 06-2026 08-2026: 0.2%● unchanged vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.2%● unchanged vs 09-2026
Credit of up to €21,000 on 30-day terms is acceptable
Liquidity insufficient (current ratio 0.67, compared with 0.39 in 2024, below 1; short-term debt: 9% and cash: 4.6% of total assets), and 9.7% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro): better than 81% on solvency, 52% on liquidity, 64% on profitability and 70% on growth.

The bankruptcy probability was computed on 30-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Size: total assets €266,668
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Founded in 2009
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
raises risk · No registered site in the KBO
KBO · seat and establishments
lowers risk · Equity €240,854 (90.3% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-05-2026, 63 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
63 days early
2024
59 days early
2023
60 days early
2022
66 days early
2021
64 days early
2020
46 days early
2019
50 days early
← before the deadline after the deadline →
tick = median of all Belgian filings

This company filed its last 7 accounts on average 58 days before the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 29 May (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
31-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Annual accounts filedfinancial year 2024 · micro…
  3. Highest result from 2018 to 2025net €31,353 ▲10.8%

Key points

  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Positive: 8 profitable years in a rowprofit 2025: €25,638 8 years View
  • Board2 directors in office 2 View

By topic

Financials

Financial year
2025
Total assets
€266,668
Profit
€25,638
Solvency
90.3%
Total assets▼ 9.7%
Net result
20182025
Go to Financials

Board & ownership

Board
2 members
Largest shareholder
DOKTER PIETER VAN ACKER · 49%
  • PAULISSEN SaskiaDirector
  • Pieter Van AckerDirector
Go to Board & ownership

Timeline

Events
21
Since
2011
Next accounts
by 31-07-2027
  1. 31-12-2024Equity above €200,000
  2. 01-06-2024Annual accounts filed
  3. 26-05-2023Annual accounts filed
Go to Timeline

Company details

Legal form
Private limited company
Founded
07-04-2009
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
29
Purpose
“Het verwerven door aankoop en/of bouw van alle onroerende goederen; De verhuring van…” (deed in Dutch)
Go to Articles of association

Key facts about AAGEM MEDICS

What is the company number of AAGEM MEDICS?
0811.003.043. In Belgium the VAT number is the company number with BE in front: BE 0811.003.043.
Where is AAGEM MEDICS based?
The registered office is at Sint-Onolfsdijk (DEN) 16, 9200 Dendermonde.Company details
What is the legal form of AAGEM MEDICS?
Private limited company (BV).
When was AAGEM MEDICS founded?
On 07-04-2009.
Is AAGEM MEDICS still active?
Yes, AAGEM MEDICS is an active enterprise in the KBO register.
How many employees does AAGEM MEDICS have?
On average 0.8 full-time equivalents in financial year 2018, according to the filed annual accounts.Financials
What is the turnover of AAGEM MEDICS?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is AAGEM MEDICS profitable?
In financial year 2025, AAGEM MEDICS made a profit of €25,638.
Where can I find the annual accounts of AAGEM MEDICS?
AAGEM MEDICS filed 16 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of AAGEM MEDICS due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to AAGEM MEDICS

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.